My treatment approach to the management of ulcerative colitis.
Level V
Where this comes from
- Record sourced from PubMed, PMID 23910410.
- Also identified by DOI 10.1016/j.mayocp.2013.05.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ulcerative colitis diagnosis and management represent a challenge for clinicians. The disguises of ischemia and acute infectious colitis continue to confound the diagnosis. The therapeutic options have remarkably expanded in the way of immunomodulators, biologics, or ileoanal pouch surgery, yet all carry potential considerable risks. These risks can confuse and impair patient acceptance, particularly elderly patients and men younger than 30 years. Predictors of outcome of medical and surgical therapy have improved but are far from complete. Nevertheless, therapies focused on the specific patient's condition continue to offer hope.
Medical subject headings
- Antibodies, Monoclonal
- Colectomy
- Colitis, Ulcerative
- Immunologic Factors
- Mesalamine
- Probiotics